Related Experiment Video
Updated: May 19, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
ZDHHC14-driven RUNX2 S-palmitoylation attenuates ferroptosis and enhances chemoresistance in ovarian cancer via the
1Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.
Abstract:
Chemoresistance and ferroptosis inhibition in ovarian cancer (OC) may contribute to tumor progression. This study aimed to investigate the role of RUNX2 in regulating ferroptosis and cisplatin (CDDP) resistance in OC, along with its post-translational modification mechanisms. Parental and CDDP-resistant OC cell lines, as well as xenograft models in nude mice, were employed to explore the molecular functions of RUNX2. Cellular function and drug resistance were assessed using cell counting kit-8, colony formation, and flow cytometry. Ferroptosis activity was evaluated by measuring protein markers (FTH1, GPX4, and ASCL4), reactive oxygen species, Fe2+, GSH/GSSG, malondialdehyde, and lipid peroxidation levels. The palmitoylation of RUNX2 were assessed using acyl-biotin exchange, Click-iT pull-down, and palmitoyl acyltransferase assays. Based on the predicted sites, Flag-RUNX2 wild-type and mutant vectors were constructed, and Myc-ZDHHC14 was exogenously introduced to examine ZDHHC14-mediated RUNX2 palmitoylation. The results indicated that RUNX2 significantly suppressed ferroptosis and enhanced CDDP resistance in OC both in vitro and in vivo. Downstream, RUNX2 transcriptionally regulated YAP1 and activated the YAP1/GLS1 axis. Additionally, palmitoylation of RUNX2 was observed in OC cells. Bioinformatics analysis predicted the binding of RUNX2 with palmitoyltransferase ZDHHC14. Exogenous induction of Myc-ZDHHC14 drove RUNX2 palmitoylation, an effect that was abolished by the RUNX2-C13S mutation. Further in vitro and in vivo experiments confirmed that ZDHHC14-driven palmitoylation of RUNX2-C13S inhibited ferroptosis and chemosensitivity in OC by activating the YAP1/GLS1 axis. To conclude, ZDHHC14-driven S-palmitoylation of RUNX2 inhibits ferroptosis and CDDP sensitivity in OC by positively regulating the YAP1/GLS1 axis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...